Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features
Study question: Are differences in androgen levels among women with various forms of ovarian dysfunction associated with cardiometabolic abnormalities?
Summary answer: Androgen levels differed substantially between women with and without ovarian dysfunction, and increased androgen levels were associated with impaired cardiometabolic features in all women irrespective of their clinical condition.
What is known
Recent evidence suggests that ovarian dysfunction, particularly in conditions like Polycystic Ovary Syndrome (PCOS), is closely linked to metabolic syndrome, insulin resistance, and an increased risk of cardiovascular disease. However, the specific contribution of androgen variations across different phenotypic presentations of ovarian dysfunction requires further clarification.
Study design, size, and duration
This observational study involved a cross-sectional analysis of women presenting with various forms of ovarian dysfunction compared against healthy controls. Participants were evaluated for hormonal profiles, anthropometric markers, and lipid metabolism metrics.
Main results and the role of chance
Our findings indicate that hyperandrogenism is a key mediator in the observed cardiometabolic risk. We observed a significant positive correlation between serum androgen concentrations and markers of systemic inflammation, even after adjusting for body mass index (BMI). These results underscore the importance of monitoring androgen levels as a predictor of early cardiometabolic decline.